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Meningococcal lipoprotein, Factor H binding protein (FHbp), is the sole antigen of the
Trumenba vaccine (Pfizer) and one of four antigens of the Bexsero vaccine (GSK)
targeting Neisseria meningitidis serogroup B isolates. Lipidation of FHbp is assumed
to occur for all isolates. We show in the majority of a collection of United Kingdom
isolates (1742/1895) non-synonymous single nucleotide polymorphisms (SNPs) in the
signal peptide (SP) of FHbp. A single SNP, common to all, alters a polar amino
acid that abolishes processing: lipidation and SP cleavage. Whilst some of the FHbp
precursor is retained in the cytoplasm due to reduced binding to SecA, remarkably
some is translocated and further surface-localized by Slam. Thus we show Slam is not
lipoprotein-specific. In a panel of isolates tested, the overall reduced surface localization
of the precursor FHbp, compared to isolates with an intact SP, corresponded with
decreased susceptibility to antibody-mediated killing. Our findings shed new light on the
canonical pathway for lipoprotein processing and translocation of important relevance
for lipoprotein-based vaccines in development and in particular for Trumenba.
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INTRODUCTION
Neisseria meningitidis is a leading cause of bacterial meningitis and sepsis with high fatality (up to
50% when untreated) and high frequency (more than 10%) of severe sequelae (Rappuoli et al.,
2018). Polysaccharide-based vaccines are effective in preventing disease caused by isolates of
serogroups A, C, W, and Y but are ineffective against those of serogroup B (MenB) (Pace and
Pollard, 2007). The lipoprotein, Factor H binding protein (FHbp), is a major virulence factor, which
recruits human factor H (fH) to the meningococcal surface preventing complement from binding to
the bacterium and thus inhibiting bacteriolysis by the alternative complement pathway (Schneider
et al., 2006). The amino acid sequence of FHbp varies with identities as low as 60% between
isolates which led to the classification of this lipoprotein into subfamily A (subdivided into variant
groups 2 and 3) and subfamily B (variant group 1) (Masignani et al., 2003; Fletcher et al., 2004;
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Brehony et al., 2009; Jiang et al., 2010). Despite this variation,
FHbp emerged as a promising vaccine candidate due to its
ability to stimulate a strong serum bactericidal antibody (SBA)
response capable of killing diverse group B isolates (Fletcher
et al., 2004). It is thought that FHbp-specific antibodies not only
promote bactericidal killing by the classical pathway but also via
amplification of the alternative pathway, by preventing fH from
binding to FHbp (Giuntini et al., 2011).
Lipoproteins, such as FHbp, are synthesized as precursors
(preprolipoproteins) in the cytoplasm, which are subsequently
taken through a sequential pathway for processing and sorting
to the outer membrane (OM) (Kovacs-Simon et al., 2011;
da Silva et al., 2017). The N-terminal signal peptide (SP),
characteristic of bacterial lipoproteins, comprises a positively
charged n-region, a hydrophobic h-region and a c-region
with the consensus sequence [LVI][ASTVI][GAS] followed
by an invariant C residue, known as the lipobox (Babu
et al., 2006). Translocation of the preprolipoprotein across
the inner membrane (IM) occurs predominantly via the
general secretory or Sec pathway (Driessen and Nouwen,
2008). Both the n-region and h-region are involved in
interaction with SecA or other chaperones which deliver the
precursor protein to the Sec-YEG transmembrane channel (Mori
et al., 1997). Preprolipoprotein diacylglyceryl transferase, Lgt,
transfers the diacylglyceryl group from phosphatidylglycerol
to the conserved C residue (Sankaran and Wu, 1994). This
diacylglyceryl modification of preprolipoproteins is vital for
substrate recognition by the dedicated lipoprotein signal
peptidase LspA which cleaves the SP (Tokunaga et al., 1982;
Inouye et al., 1983; Vogeley et al., 2016). In diderms, such as
Neisseria, the amino group of the C residue is further modified
with a third acyl chain through apolipoprotein N-acyltransferase,
Lnt (da Silva et al., 2017). Fully processed lipoproteins (cleaved
and lipidated) that are destined to be anchored to the OM are
transported by the Lol (lipoprotein OM localization) machinery
(Tokuda, 2009). We previously showed that in N. meningitidis,
Lol consists of the IM ABC transporter-like complex, LolFD
(as opposed to LolCDE of Escherichia coli) the periplasmic
LolA chaperone and the OM LolB lipoprotein receptor (da
Silva et al., 2017) (Figure 1). FHbp is then surface localized
by lipoprotein assembly modulator (Slam) (Hooda et al., 2016).
Slam either acts as a conduit for FHbp or delivers it to another
OM protein or to a complex such as Bam (Hooda et al.,
2016) (Figure 1).
Through an accelerated approval process, both Trumemba
(Pfizer) and Bexsero (GSK) were licensed by the FDA in 2015
for immunization to prevent invasive disease by meningococcal
group B in the United States in individuals 10 to 25 years of
age. Trumenba comprises two recombinant FHbps, one from
subfamily A, the other from subfamily B, both containing the
lipid moiety found in the native protein (Fletcher et al., 2004;
Gandhi et al., 2016). A recombinant non-lipidated form of
FHbp from subfamily B is also one of the antigens of the
Bexsero vaccine (GSK) (Vernikos and Medini, 2014) licensed
for infants from 2 months of age in Europe in 2013 and now
in Canada, Australia and several counties in South America
(Basta and Christensen, 2016).
A concern however for FHbp-based vaccines is the variation
in expression level of FHbp between strains by over 15-fold
and a threshold level of expression of at least 757 molecules of
FHbp per cell is required for killing by FHbp-specific antibodies,
meaning that isolates with low FHbp surface decoration fail
to be effectively targeted (Jiang et al., 2010; Zlotnick et al.,
2015; Biagini et al., 2016). The regulation of FHbp expression
is influenced by external factors; at the transcriptional level by
both iron and oxygen availability and at the translational level,
by temperature (Oriente et al., 2010; Sanders et al., 2012; Loh
et al., 2016). Our work has focused on bacterial-cell-intrinsic
molecular factors, which govern the processing and localization
of FHbp to the surface (da Silva et al., 2017) (Figure 1) which is
key for target recognition following immunization with FHbp-
based vaccines.
One of the studies correlating surface exposure of FHbp and
susceptibility to killing by anti-FHbp antibodies was conducted
by Newcombe et al. (2014) [27]. While strain L91543 displayed
very little FHbp at the surface and demonstrated lack of killing
by anti-FHbp sera, strain MC58, a well-characterized reference
strain, demonstrated strong surface expression of FHbp and
efficient killing by anti-FHbp sera (Newcombe et al., 2014).
We further observed a difference in size in FHbp between
these two strains, despite their high amino acid (AA) sequence
identity across the same length open reading frame (Figure 2A)
(Karlyshev et al., 2015). The FHbp of strain MC58 is of the
expected size; 27 kDa (Schneider et al., 2009) and is known
to be tri-palmitoylated at the C residue (Mascioni et al.,
2010) whereas the FHbp of L91543 is about 3 kDa larger
(Figure 2A) (Karlyshev et al., 2015). We identified two non-
synonymous single nucleotide polymorphisms (SNPs) in the
h-region of the FHbp SP of L91543 that we hypothesized
affects translocation and processing and ultimately localization
to the cell surface (Karlyshev et al., 2015). In this study,
by restoring these SNPs we provide strong evidence to
support our hypothesis.
Surprisingly we found that the majority of invasive isolates
circulating in the United Kingdom carry these SP SNPs and
exclusively express the preprolipoprotein, which is partially
retained in the cytoplasm due to reduced binding to SecA. Of
the precursor protein that is translocated to the IM, some is
retained in the periplasm and some exported to the surface.
Our data suggest translocation to the OM is facilitated by Lnt
and surface display is conducted by Slam following escape from
processing by Lgt and LspA. Our findings thus suggest novel
roles for Lnt as a chaperone facilitating periplasmic transport
and for Slam in localizing non-lipidated FHbp to the cell surface.
We show that the reduced surface display of precursor FHbp,
due to cytoplasmic retention, correlated with reduced killing
by FHbp-specific antibodies. Knowledge of the SP sequence of
isolates in addition to the promoter and upstream regulatory
sequence of FHbp (Cayrou et al., 2018) will enable improved
prediction of surface abundance and thus coverage by Trumenba.
New algorithms can now be deployed to predict whether other
preprolipoproteins are processed to become mature lipoproteins
or remain as precursors. This manuscript has been released as a
Pre-Print at BioRxiv (da Silva et al., 2019).
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FIGURE 1 | Model pathway for translocation, processing, sorting, and export of FHbp in Neisseria meningitidis. Preprolipoproteins are synthesized in the cytoplasm
and as they emerge from ribosomes bind chaperones such as SecA, which translocate them across the IM via SecYEG. Lgt disacylates the preprolipoprotein at the
conserved C residue of the lipobox of the SP, next LspA cleaves the SP exposing the C residue for further acylation by Lnt (da Silva et al., 2017). The Lol apparatus
(LolFD) in N. meningitidis sorts the triacylated lipoprotein to the OM by delivering this to chaperone LolA, which releases the mature lipoprotein to the OM lipoprotein
acceptor, LolB (da Silva et al., 2017). SLAM then localizes FHbp to the cell surface (Hooda et al., 2016).
MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
Escherichia coli strain JM109 single use competent cells were
purchased from Promega and used for transformations in
E. coli. BTH101 (Euromedex) was used as a reporter strain
for BACTH assays.
The two reference (control) strains of N. meningitidis used
in this study are MC58, serogroup B:15:P1.7,16, ST-74; ET-5
purchased from LGC Standards and L91543 serogroup C:2aP1.2,
ST-11; ET-37 kindly provided by Professor McFadden (University
of Surrey) (Table 1). Strain H44/76, serogroup B:P1.7,16:F3-3:
ST-32 was gifted by Rob Read and all other group B isolates
were given by Christopher Bayliss with approval from Ray
Borrow (Public Health England) (Table 2) and are listed in
the Meningococcus Genome Library database (MRF collection).
These isolates were obtained from patients in England, Wales,
Northern Ireland and Scotland from 2009 to 2017.
Escherichia coli strains were grown at 37◦C in Lysogeny
broth (LB) with shaking at 200 rpm or on agar (Merck). All
meningococcal strains were grown on GC agar plates or GC
broth (Difco) containing Kellogg’s glucose and iron supplements
(Kellogg et al., 1963) in a moist atmosphere containing 5% CO2
at 37 or 30◦C for transformation experiments and with shaking
at 220 rpm for broth cultures.
Antibiotics were purchased from Sigma and added at
the following concentrations: kanamycin, 30 and 60 µg/ml,
erythromycin, 300 and 0.3 µg/ml for E. coli and N. meningitidis
respectively; 100 µg/ml ampicillin for E. coli; and 30 µg/ml
nalidixic acid for E. coli BTH101.
Antibodies
Mouse anti-FHbp-Mabs, JAR4 and JAR5, were obtained from
NIBSC. JAR4 is IgG2a and JAR5 is IgG2b; both were obtained
from mice immunized with recombinant FHbp derived from
MC58 (Welsch et al., 2004). Mouse anti-FHbp polyclonal
antibody was kindly provided by Christoph Tang and rabbit anti-
RecA IgG was purchased from Abcam. Factor H protein was
purchased from Bio-Rad and the mouse monoclonal IgG1 Factor
H Antibody (OX24) conjugated with PE purchased from Santa
Cruz Biotechnology. Secondary antibodies included donkey anti-
rabbit HRP-linked IgG, sheep anti-mouse HRP-linked IgG (GE
Healthcare, United Kingdom) for Western immunoblotting and
rat anti-mouse IgG H + L conjugated with FITC for FACs
analysis (Thermo Fisher Scientific).
SDS-PAGE, Western Immunoblotting,
and Immuno-Dot Blotting
Whole cell lysates (WC) were prepared from broth or plate
cultures resuspended in PBS fractionated by 12 or 16% (w/v)
SDS-PAGE and immunoblotted as described previously (da
Silva et al., 2017). For immunoblotting, membranes were
incubated with JAR4 (diluted 1:1000 from 1 mg/ml stocks)
or rabbit anti-RecA antibody diluted (1:1000) for 1 day,
washed then incubated with either sheep anti-mouse or
donkey anti-rabbit HRP-linked secondary antibody. Protein
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FIGURE 2 | Cleavage and surface localization of FHbp in L91543 upon transformation with MC58 fHbp. WCL (A,B,D) and whole cell suspensions from fresh plate
cultures (A,C), or from broth cultures (B), analyzed by Western immunoblot and immuno-dot blot respectively with JAR4. (A) Western immunoblot (upper panel) and
immuno-dot blot (lower panel) of strains L91543 and MC58. (B) Different growth phases of broth cultures of MC58 and L91543 analyzed by Western immunoblot
(upper panel), including anti-recA antibody to verify loading control, and immuno-dot blot (lower panel), representative of three independent experiments.
(C) Immuno-dot blot and (D) Western immunoblot: Lanes; 1, L91543; 2, MC58; 3, L91543fHbpMC58. Data are representative of five independent experiments. For
(C), the reflective density was measured by a GS-800TM calibrated densitometer. The one way ANOVA followed by Dunnett’s test was employed for statistical
analysis in GraphPad (V. 6). All columns represent mean ± SEM, ∗p < 0.05 vs. strain MC58.
bands were detected by enhanced chemiluminescence (GE
Healthcare, United Kingdom) or 3,3′,5,5′-tetramethylbenzidine
(TMB) (Sigma). Band intensity was quantified using a GS-
800TM calibrated densitometer (Bio-Rad) or ImageJ 1.x
(Schneider et al., 2012) calibrated to perform Optimal
Density (OD) based on a pallet of colors in grayscale.
Immuno-dot blots were performed as described previously
(da Silva et al., 2017).
Palmitate Labeling of Lipidated Proteins
Bacterial cultures were grown in supplemented GC broth then
after an initial doubling period, alkyne-labeled palmitic acid
(Cayman Chemical) was added to a final concentration of 45 µM.
Bacteria were incubated for at least four more hours at 37◦C.
Immuno-Precipitation of FHbp From
Precipitated Supernatant
Samples were immuno-precipitated with Protein G Mag
Sepharose (GE Healthcare Life Sciences) and Mab JAR4.
Following incubation of 100 µl of precipitated sample with
5 µg of JAR4 overnight at 4◦C, samples were incubated for
1 h with 100 µl of magnetic bead slurry. Using a magnetic
particle concentrator (MPC), beads were washed twice with PBS
and FHbp recovered following the addition of 100 µl 0.1M
glycine-HCl (pH 2.5 to 3.1). Buffer exchange from glycine-
HCl buffer to click reaction buffer (100 mM Na-Phosphate
Buffer, pH 7) was performed with Slide-A-Lyzer Dialysis
cassettes (Sigma).
Click Chemistry
The Click Chemistry labeling system “CuAAC Biomolecule
Reaction Buffer Kit (THPTA based)” (Jena Bioscience) was
used following manufacturer’s instructions (Ostberg et al., 2013).
FHbp was coupled to biotin azide (Stratech) then samples
fractionated on 10–20% (w/v) SDS-PAGE gels (Novex). Western
immunoblotting was performed by incubating the membrane
with Streptavidin HRP-linked protein in PBS-BSA buffer and
developing with TMB (Sigma).
Harvesting Cellular Compartments of
N. meningitidis
Periplasmic extracts were prepared using a method previously
described (Ames et al., 1984). Cells from over-night GC plate
cultures were suspended to A600 1.0 in 500 µl buffer (50 mM
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TABLE 1 | Frequency of different FHbp SP classes in capsular group B isolates in the MRF Meningococcus Genome Library database.
SP class SP sequence No. of isolates (%) n = 1895 Isolates used in this study
1 (NO SNPs) MTRSKPVN R TAFCCLSLTTALI LTAC 171 (9) MC58 and 1–4
2 (SNP1 and SNP2) MTRSKPVN R TAFCCFSLTAAU LTAC 435 (23) L91543 and 10–13
SNP1 SNP2
3 (SNP2) MTRSKPVN R TAFCCLSLTAALI LTAC 910 (48) 5–9
SNP2
4 (SNP2 and SNP3) MTRSKPVN R TTFCCLSLTAALI LTAC 323 (17) 14–18
SNP3 SNP2
Other SNPs 56 (3)
The n-region is shown in brown, h-region in green and lipobox in red, corresponding to the display generated by the DOLOP lipoprotein prediction program (https:
//www.mrc-lmb.cam.ac.uk/genomes/dolop/analysis.shtml) (Babu et al., 2006).
TABLE 2 | MenB invasive isolates used in this study.
Class Isolate number Isolate, full name
1
– MC58
1 H44/76
2 M10_240684
3 M10_240701
4 M02_241729
2
5 M10_240579
6 M13_240525
7 M04_241215
8 M11_241066
9 M13_240614
3
– L91543
10 M10_240750
11 M13_240675
12 M11_240236
13 M12_240006
4
14 M11_241033
15 M14_240367
16 M02_240210
17 M11_240077
18 M13_240486
The SP class is indicated for each isolate.
Tris-HCl pH 8.0) and pelleted at 3,500 × g for 2 min.
The pellet was resuspended in 200 µl of the same buffer
and 20 µl of chloroform was added. After brief vortexing,
tubes were incubated for 15 min at room temperature. After
centrifugation at 6,500 × g for 2 min, the upper portion
of the supernatant, containing the periplasmic proteins, was
carefully aspirated and placed in a second tube. The pellet
containing the remaining IM, OM, and cytoplasmic proteins
was partitioned following approaches adapted from two different
research groups (Clark et al., 1987; Rahman et al., 2000).
The pellet was re-suspended in 500 µl buffer [50 mM Tris-
HCl pH 8.0, 20% (w/v) sucrose] containing 1 mg/ml lysozyme
and incubated for 30 min at 4◦C. After two cycles of freeze-
thawing, the cells were subjected to sonication (2 bursts of 30 s).
Cellular debris were removed by centrifugation at 9,500 × g
for 10 min. Ultra-centrifugation at 100,000 × g for 60 min
enabled partitioning of the membranes in the pellet from
cytoplasmic proteins in the supernatant. The IM was selectively
solubilized by treatment with 200 µl of 1% (w/v) sodium lauroyl
sarcosinate in 10 mM HEPES (N-2-hydroxyethylpiperazine N′-
2-ethanesulfonic acid) pH 7.4 buffer. After centrifugation at
100,000 × g for 1 h the supernatant containing solubilized
IM proteins was separated from the pellet containing OM
proteins. The pellet was washed with ethanol and resuspended
in 200 µl PBS.
Molecular Methods for DNA
Manipulations
Genomic DNA was extracted from N. meningitidis using
the Gentra Puregene Yeast/Bact Kit (Qiagen) and plasmid
DNA was extracted from E. coli using the QiaPrep Spin
kit (Qiagen). DNA samples were analyzed by agarose gel
electrophoresis and visualized by staining with SYBR Safe
(Invitrogen). Restriction enzymes (NEB), T4 DNA ligase
(Promega), and Antarctic Phosphatase (NEB) were used
according to the manufacturer’s recommendations. PCRs were
performed using Q5 polymerase kit (NEB) in a Perkin- MJ
Research PTC-200 Peltier Thermal Cycler or C1000 TouchTM
Thermal Cycler (Bio-Rad). Primers were purchased from Sigma
and their sequences listed in Table 3. PCR products and
restriction digested DNA were purified using the PCR Mini
Elute kit (Qiagen). E. coli was transformed by heat shock
(Froger and Hall, 2007).
Genome Sequencing
The N. meningitidis L91543 genome sequence was completed
using a hybrid approach employing a combination of short
and long reads assemblies produced by IonTorrent (Karlyshev
et al., 2015) and PacBio technologies. PacBio sequencing
was conducted at TGAC (The Genome Analysis Centre,
Norwich, United Kingdom) using an RSII sequencing machine
with P6/C4 sequencing chemistry and a single SMRT cell.
When analyzing the PacBio assembly, long redundant regions
were detected at the ends of the sequence. CLC Genomics
Workbench software and high quality reads generated by
IonTorrent PGM were used for elimination of artifactual
redundancies and for circularization, as well as for final
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TABLE 3 | PCR primer pairs used in this study.
PCR, sequencing and RT-PCR
Primer name Primer sequence
fHbp cloning (restriction sites underlined)
PacI-fHbp-for 5′-GCGCAATTAATTAATTGCTTCTTTGACCTGCC-3′
PmeI-fHbp-rev 5′-ACCTGTTTAAACAATGGTTATTGCTTGGCG-3′
pGCC4 sequencing primers
pGCC4-fwd 5′-AGACATCCGCCAAACCATCC-3′
pGCC4-rev 5′-TGCTTCCGGCTGTTGTGTGG-3′
RT-PCR primers
fHbp-for 5′-GTTTCGCAACCATCTTCCCG-3′
fHbp-rev 5′-GACTTTATCCGTCAAATCGA-3′
recA-for 5′-GAAGAGGTATTGGCAACGA-3′
recA-rev 5′- CGGATTTGTTGATGATGTCG-3′
Bacterial two-hybrid (restriction sites underlined)
BamHIfwd_MC58FHbp 5′-GCGAGGATCCATGACTAGGAGTAAACCTGTGAATC-3′
EcoRIrev_MC58FHbp 5′-GATCGAATTCTTATTGCTTGGCGGCAGGCCGATATG-3′
BamHIfwd_L91543FHbp 5′-GCGAGGATCCATGCCGTCTGAACCGTTGTTCGGACGGC-3′
EcoRIrev_L91543FHbp 5′-GATCGAATTCTTACTGCTTGGCGGCAAGACCGATATGG-3′
PstIfwd_SecA 5′-CGATCTGCAGATGCTGACAAACATTGCCAAGAAAATC-3′
SmaIreverse_SecA 5′-CGACCCGGGTTAAGCCAGTTTGCCGTGGCATTG-3′
Site-directed mutagenesis (incorporated mutations italicized)
SP1_Fwd 5′-CTTCTGCTGCCTTTCTCTGACCG-3′
SP1_Rev 5′-GCAGTTCGGTTCACAGGT-3′
SP2_Fwd 5′-TTCTCTGACCACTGCCCTGATTC-3′
SP2_Rev 5′-AAGCAGCAGAAGGCAGTT-3′
Deletion of fHbp by SOEing
HA1_FHbp_Fwd 5′-GATAGAATTCCGAGTATGCAGCTTTG-3′
Rev_HA1_FHbp 5′-GATGATGGTTGCCATTGTGAAAATGCCGTCC-3′
Kan_fwd 5′-TTCACAATGGCAACCATCATCGATG-3′
Kan_rev 5′-AAACCTTTCAGACGGCATGTAATGCTCTGCC-3′
HA2_FHbp_fwd 5′-ATGCCGTCTGAAAGGTTTACTCCTAGTCATACG-3′
HA2_FHbp_rev 5′-CTTAGGATCCCCACGGCGCATACAAATTC-3′
Deletion of slam by SOEing (kan sequence in bold, HA sequence underlined, overlapping sequence italicized)
HA1_0313_Fwd 5′-GATAGAATTCAGGCGCAGTTTACCTACTTG-3′
HA1_0313_rev 5′-GATGATGGTTGTATCAATCGGCGGATTGTATC-3′
0313_Kan_fwd 5′-GATACAATCCGCCGATTGATACAACCATCATCGATG-3′
0313_Kan_rev 5′-AACAGCAATTCAGACGGCATGTAATGCTCTGCC-3′
HA2_0313_fwd 5′-ATGCCGTCTGAATTGCTGTTCCTTTTCGGAGG-3′
HA2_0313_rev 5′-CTTAGGATCCGAACGGCTTATGGCTTTGGGAC-3′
Disruption of Lnt
Lnt_fwd 5′-GGCAGGAGATATGCGCTAAG-3′
Lnt_rev 5′-GTACTGGTCGCCCACAACCT-3′
verification of the sequence and correction of any errors
produced by PacBio.
BLAST Analysis
Whole genome sequence (WGS) data from capsular
group B isolates with complete FHbp profiles in
the Meningitis Research Foundation Meningococcus
Genome Library database (containing WGS data from all
United Kingdom disease isolates from 2010 to 2017) was
interrogated using the BLAST tool implemented within the
PubMLST.org/neisseria database using default settings (last
analyzed September, 2018).
Construction of Strain L91543fHbpMC58
The region incorporating the promoter and open reading
frame of fHbp was PCR-amplified from MC58 genomic DNA
with primers PacI-fHbp-for and PmeI-fHbp-rev (Table 3)
digested with PacI and PmeI sites and cloned into the
PacI, PmeI sites of Neisseria complementation vector, pGCC4
(Addgene) (Mehr and Seifert, 1998). The resulting plasmid,
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pGCC4fHbpMC58 was verified by DNA sequencing with
pGCC4 primers (Table 3) and the plasmid used to transform
N. meningitidis strain L91543 as previously described (Zhang
et al., 2010) with selection on erythromycin. A transformant
was verified by PCR with subsequent DNA sequencing and
designated L91543fHbpMC58. The same approach was used to
create plasmid pGCC4fHbpL91543 with the L91543 version of
fHbp, which was used for site-directed mutagenesis.
Construction of Strain L915431fHbp
Gene Splicing by Overlap Extension (gene SOEing) was used to
create a fusion PCR product to replace fHbp in strain L91543
with the kanamycin resistance gene (kan) from EZ:Tn5 < KAN-
2 > insertion kit (Epicentre) following the approach described
by Horton (Horton, 1995). In the first round of PCRs, homology
arms (HA1 and HA2) of approximately 600 bp flanking fHbp
were amplified from genomic DNA of L91543 using primers,
HA1_FHbp_Fwd and Rev_HA1_FHbp and HA2_FHbp_fwd and
HA2_FHbp_rev, and the kan gene was amplified using primers
Kan_fwd and Kan_Rev. As shown in Table 3, in bold are
the regions that bind to kan, underlined are the regions that
bind to the HA of interest and in italics are the regions that
over-lap. The HA1 and kan PCR products obtained were gene-
cleaned then used as template for the second round of PCR
with primers HA1_FHbp_Fwd and Kan_Rev and the annealed
product generated cleaned and used as template along with
the HA2 PCR product for a third round of PCR with primers
HA1_FHbp_Fwd and HA2_FHbp_rev. The final PCR product
generated containing HA1-kan-HA2 was gene cleaned and
sequenced for confirmation. The verified construct was used to
transform strain L91543 with selection on kanamycin. Deletion
mutants were confirmed by PCR and DNA sequencing and
designated L915431fHbp.
Disruption of Slam
In the same manner as that described above, the gene encoding
Slam (NMB0313) was replaced with kan. For the first round
of PCRs, primers HA1_0313_Fwd and HA1_0313_rev and
HA2_0313_fwd and HA2_0313_rev were used to amplify
approximately 600 bp of sequence flanking slam from
genomic DNA of MC58 and kan was amplified with primers
0313_Kan_fwd and 0313_Kan_rev (Table 3). The appropriate
primer pairs were used in second and third round PCR
and the construct confirmed by sequencing then used to
transform MC58, L91543 and isolates 6 and 18 with selection
on kanamycin. Insertion mutants were confirmed by PCR and
DNA sequencing and designated MC58Slam, L91543Slam,
Isolate6Slam, and Isolate18Slam.
Disruption of Lnt
Primers, Lnt_fwd and Lnt_rev (Table 3), annealing
approximately 600 bp upstream and downstream respectively
of lnt in strain MC58Lnt, were used to amplify lnt that had
been disrupted by the insertion of Tn5 < KAN-2 > (Epicentre)
(da Silva et al., 2017). The PCR product generated was used
to transform L91543 and isolates 6 and 8 with selection on
kanamycin. Deletion mutants were confirmed by PCR and
DNA sequencing and designated L91543Lnt, Isolate6Lnt,
and Isolate18Lnt.
Site-Directed Mutagenesis
Site-directed mutagenesis of the fHbp SP in pGCC4fHbpL91543
to repair SNP1 and SNP2 individually was performed using
the Q5 R© Site-Directed Mutagenesis Kit (NEB) according to the
manufacturer’s recommendations. SNP1 was corrected to create
plasmid pGCC4LfHbpSNP1 and SNP2 was corrected to create
plasmid pGCC4LfHbpSNP2. Seven ng of pGCC4fHbpL91543
and 0.5 µM of each pair of primers (Sigma) were used for
amplification and incorporation of the desired mutation. Primers
SP1_Fwd and SP1_Rev, and SP2_Fwd and SP2 _Rev (Table 3)
were used to incorporate SNP1 and SNP2 respectively. PCR was
performed in a C1000 TouchTM Thermal Cycler (Bio-Rad) with
the following thermo-cycling conditions; 98◦C for 30 s followed
by 25 cycles of 98◦C for 10 s (denaturation), 68◦C for 15 s
(annealing), 72◦C for 3 min and 25 s (extension) and 72◦C for
2 min (final extension). One µl of the PCR product was kinase-,
ligase-, and DpnI- treated (KLD treatment) and incubated for
5 min at room temperature. Five µl of the KLD mix was then
used to transform competent cells. After plating on LB agar
with kanamycin and incubating overnight, several colonies were
isolated, grown individually in LB broth with kanamycin and
plasmid DNA extracted and sequenced with pGCC4 primers
(Table 3) for verification. To repair both SNPs, the PacI-PmeI
fragment of pGCC4fHbpL91543 was commercially synthesized
(Life Technologies) with the two SNPs repaired to resemble the
fHbp SP of MC58 and the DNA cloned into the PacI-PmeI sites
of pGCC4 to create pGCC4LfHbpSNP1 + 2. The construct was
verified by sequencing with pGCC4 primers (Table 3).
Strain L915431fHbp was transformed with pGCC4
fHbpL91543 to create L915431fHbpLfHbp with no SNP
corrections as a negative control. The same strain was
transformed with pGCC4LfHbpSNP1 to generate recombinant
strain L915431fHbp + LfHbpSNP1, with pGCC4LfHbpSNP2
to generate strain L915431fHbp + LfHbpSNP2 and finally
with pGCC4LfHbpSNP1 + 2 to create strain L915431fHbp +
LfHbp SNP1+ 2.
Bacterial Two-Hybrid Assay (BACTH)
The protein–protein interaction of MC58 FHbp and L91543
FHbp with SecA was investigated using the Bacterial Adenylate
Cyclase Two-Hybrid System Kit (Euromedex) according
to manufacturer’s instructions. First, fHbp from MC58
and from L91543 was PCR-amplified with the primer pair
BamHIfwd_MC58FHbp and EcoRIrev_MC58FHbp and primer
pair BamHIfwd_L91543FHbp and EcoRIrev_L91543FHbp
respectively (Table 3) then the PCR products cloned separately
into vector pUT18. The gene encoding SecA from MC58
was PCR-amplified with primer pair, PstIfwd_SecA and
SmaIreverse_SecA (Table 3) then cloned into vector pKT25.
25–50 ng of the appropriate prey (pKT25-based construct) and
the equivalent concentration of appropriate bait (pUT18-based
construct) were co-transformed into 100 µl of competent
E. coli BTH101 cells and plated on MacConkey agar containing
0.5 mM IPTG and appropriate antibiotics. Bacteria expressing
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interacting hybrid proteins formed pink/purple colonies while
cells expressing non-interacting proteins remained white/light
pink. As a positive control, a co-transformant containing
commercial pKT25-zip and pUT18-zip constructs was used. Co-
transformants containing empty vector pKT25 and/or pUT18
were used as negative controls. Pink colonies were isolated and
grown in LB broth and plasmid DNA extracted for verification
by PCR and sequencing.
β-Galactosidase Assay
Following the approach previously described (Chambonnier
et al., 2016), to measure the level of protein–protein interaction
between FHbp from MC58 or L91543 with SecA, LB broth
cultures were grown to A600 0.6 then induced for 3 h with
0.5 mM IPTG. Five µl of induced culture were mixed with
900 µl of Z buffer (0.06M Na2HPO4 2H2O, 0.04M NaH2PO4,
0.01M KCl, 2 mM MgSO4.7H2O, 14.20M β-mercaptoethanol
(pH 7), before addition of 20 µl of 0.1% (w/v) SDS and
100 µl of CHCl3 to permeabilize the cells. Substrate solution
was prepared by solubilizing orthonitrophenyl-β-galactosidase
(Sigma) in Z buffer without the β-mercaptoethanol to a final
concentration of 4 mg/ml. 40 µl of substrate solution were
added to 180 µl of Z buffer and 20 µl of permeabilized
cells in a 96-well plate. The plate was incubated at room
temperature for at least 20 min. Readings were taken on a
microplate reader at A405 and A540 and β-galactosidase activity
calculated using the equation below and expressed in Miller units.
β− galactosidase activity =
1000 × (A405 − A540)
Time (min) × vol. of cells in assay (ml) × A600
FACS Analysis of Isolates to Measure the
Number of JAR4 Antibodies Bound per
Cell (ABC) and Quantify Surface
Localization of FHbp
FHbp surface expression was assessed using a MoFlo Astrios EQ,
Cell Sorter (Beckman Coulter). The approach used was similar
to that described previously (Biagini et al., 2016). Approximately
1 × 105 bacteria were suspended in PBS containing 1% (w/v)
bovine serum albumin (PBS-BSA) and incubated with JAR4 in
a final volume of 100 µl for 1 h at 37◦C. After two washes
with PBS, JAR4 binding was detected using FITC-conjugated
rat anti-mouse IgG (H + L) (Thermo Fisher) at a 1:50 dilution
for an incubation period of 1 h. After the final two washes
with PBS, samples were resuspended in 500 µl of PBS-BSA
with 4% (w/v) formalin. The negative control consisted of
cells incubated with the secondary antibody alone. QuantumTM
Simply Cellular R© anti-rat (Bang Laboratories) microspheres
were used to determine the number of ABC according to the
manufacturer’s instructions. Median channel values for each
population of microspheres were acquired for entry into the
QuickCal R© spreadsheet to generate a curve that enabled the
acquisition of ABC for each isolate.
FACS Analysis of Isolates With Anti-fH
Antibody to Quantify fH Binding
Approximately 1 × 105 bacterial cells were suspended in PBS
containing 1% (w/v) PBS-BSA and incubated with fH (Bio-Rad)
at a final concentration of 5 µg/mL for 1 h at room temperature.
After two washes with PBS, anti-fH antibody (OX-24) conjugated
to PE was added at a 1:50 dilution for 1 h. After two more
washes in PBS, samples were resuspended in 200 µl of PBS-
BSA with 4% (w/v) formalin. The negative control consisted of
cells incubated with anti-fH antibody alone. The relative Mean
of Fluorescence Intensity (rMFI) for total fluorescent cells was
acquired for each sample and these values normalized against
rMFI of cells incubated with secondary antibody alone.
Susceptibility of Isolates to Killing in
Serum Bactericidal Antibody Assays
The susceptibility of the isolates to complement-mediated killing
with antibodies JAR4 and JAR5 was assessed using approaches
adapted from previous studies (Beernink et al., 2008, 2011; Vu
et al., 2012). JAR4 and JAR5 were used in combination, in place
of serum antibodies, to generate bactericidal activity (Beernink
et al., 2008; Welsch et al., 2008; Malito et al., 2016). Eight µg of
each antibody were used to ensure maximum killing (Beernink
et al., 2008). Complement was obtained from lyophilized human
sera (Sigma) reconstituted in sterile water as per manufacturer’s
instructions. Complement and antibodies were added to IgG-
depleted human sera (Stratech) that had been heat-inactivated
for 30 min at 56◦C. The bactericidal activity, i.e., the percentage
of killing by the antibodies for each isolate was then determined
from the CFU counts after 60 min incubation in the reaction
mixture and compared with CFU counts from negative control
wells at time 0.
Reverse Transcription PCR (RT-PCR)
Following a similar approach to that we described previously
(da Silva et al., 2017), RNA was extracted from 1 ml cell
suspensions of each isolate standardized to A600 0.65 (containing
approximately 2× 108 cells) using the RNeasy Mini kit (Qiagen)
with enzymatic lysis and Proteinase K digestion. On-column
DNA digestion was performed using the RNase Free DNase kit
(Qiagen). RNA quality was assessed for genomic contamination
and integrity using a NanoDrop Lite (Thermo Fisher Scientific)
and running 1 µl of sample on a 1% agarose gel.
One µg of cDNA was synthesized using the QuantiTect
reverse transcription kit (Qiagen) with the initial genomic wipe-
out step included. RT-PCR was performed in a 50 µl reaction
mixture with One Taq 2x master mix (NEB), 20 ng of cDNA
and 0.2 µM of each primer (Sigma). For amplification of cDNA
of fHbp, fHbp-for, and fHbp-rev primers were used and for
amplification of recA, recA-for, and recA-rev primers were used
(Table 3). To qualitatively check for different levels of expression,
PCR was performed in a C1000 TouchTM Thermal Cycler (Bio-
Rad) with the following thermo-cycling conditions; 94◦C for 30 s
followed by 35 cycles of 94◦C for 15 s (denaturation), 56◦C for
15 s (annealing) and 68◦C for 20 s (extension). PCR products
were visualized on a 1% agarose gel.
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Statistical Analysis
Data are shown as mean ± SEM. Multiple comparisons between
groups were performed by one way ANOVA followed by
Dunnett’s test. Unpaired t-tests with Welsh’s corrections were
used for comparisons between two groups. A value of p ≤ 0.05
was considered statistically significant. Post hoc tests were run
if F achieved p < 0.05 and there was no significant variance.
All statistical analyses were performed in GraphPad Prism
version 6.00 for Windows. No statistical methods were used to
predetermine sample size. The experiments were not randomized
other than for selection of clinical isolates used in this study. The
investigators were not blinded to allocation during experiments
and outcome assessment.
RESULTS
SP SNPs in FHbp Prevent Cleavage but
Not Surface Localization in Strain L91543
Neisseria meningitidis strain MC58 was originally isolated from a
patient in the United Kingdom with meningococcal meningitis
(McGuinness et al., 1991) and is a fully-sequenced, commonly
used laboratory reference strain (Tettelin et al., 2000). Strain
L91543 was isolated from the cerebrospinal fluid of a 14-year old
with meningococcal meningitis in the United Kingdom (Oliver
et al., 2002). The FHbp-specific monoclonal antibody, JAR4, used
throughout this study was sourced from the National Institute
for Biological Standards and Controls (NIBSC). JAR4 binds
to an N-terminal epitope including the AA residues DHK at
positions 25 to 27 (Beernink and Granoff, 2009) (Supplementary
Table S1) and was generated following immunization of mice
with MC58 FHbp (Welsch et al., 2004). The FHbps of both
MC58 and L91543 are classified as subfamily B (Fletcher et al.,
2004; Beernink and Granoff, 2009) (variant 1) (Masignani
et al., 2003) and, as we previously reported, they share
nucleotide and AA identities of 95 and 93% respectively
(Karlyshev et al., 2015).
We investigated differences in the surface localization of
FHbp between these strains at different growth phases in a
whole cell immuno-dot blot assay. A consistent strong level
of surface expression of FHbp was shown for MC58 during
growth in contrast to L91543, which demonstrated a uniform
low level of surface localization (Figures 2A,B). Western
immunoblot analysis of whole cell lysates showed a consistent
high level of total FHbp expression for MC58, whereas the
presence of FHbp was minimal in mid-log phase and strong
only at stationary phase for L91543 cultures (Figures 2A,B).
Thus for L91543, the demonstration of strong total FHbp
level at stationary phase yet poor surface expression implies
that FHbp is retained within the cells of this strain and fails
to either sort to the OM and/or become surface-exposed,
unlike MC58.
We previously reported that the FHbp of L91543 appears
to be 3 kDa larger than that of MC58 upon fractionation of
whole cell lysates as shown in Figure 2A, this additional mass
corresponding to the size of the 26 AA SP (Karlyshev et al., 2015).
To investigate any defects in LspA, which should cleave this
SP, or aberrations in other proteins involved in the sequential
pathway for FHbp processing and export (da Silva et al., 2017)
(Figure 1), the genome of L91543 was fully sequenced (GenBank
accession number CPO16684) and BLAST analysis performed
using relevant query sequences from MC58. LspA is 100%
identical between the two strains and all other proteins
share > 97% identity with no evidence of frameshifts or
premature stop codons, whereas FHbp exhibits only 93%
AA identity between these two strains (Supplementary Table
S2). Notably the SP region of FHbp exhibits even greater
divergence due to the presence of 2 SNPs in L91543; leucine
(L) substituted by phenylalanine (F) at position 15 (SNP1)
and threonine (T) substituted by alanine (A) at position 19
(SNP2) (Table 1).
To test our hypothesis and determine whether differences
in the FHbp sequence are solely responsible for the failure to
cleave and export FHbp in strain L91543, the fHbp gene including
its upstream promoter and ribosomal binding site from MC58
was inserted into the chromosome of strain L91543. This region
was first cloned into the Neisseria complementation vector,
pGCC4, which allows integration of DNA in the intergenic region
between aspC and lctP without causing polar affects (Mehr and
Seifert, 1998; da Silva et al., 2017). Plasmid pGCC4fHbpMC58
was transformed into strain L91543 and JAR4 was used to
assess FHbp expression. Immuno-dot blot of whole cells showed
that the recombinant strain, L91543fHbpMC58, acquired the
ability to express FHbp at the cell surface (Figure 2C).
Western immunoblot analysis of L91543fHbpMC58 revealed
two bands: a lower band with a mobility equivalent to the
cleaved FHbp of MC58 and a higher molecular weight band
corresponding to the expected mobility for the native, uncleaved
protein (Figure 2D).
To investigate the specific and combined contribution
of the two individual SNPs in L91543 SP on cleavage and
export, first fHbp was deleted in L91543 (L915431fHbp) then
complemented with wild type (L915431fHbp + LfHbp)
or versions with site-directed alteration in the SP
(L915431fHbp+ LfHbpSNP1, L915431fHbp+ LfHbpSNP2, and
L915431fHbp+ LfHbpSNP1+ 2). Western immunoblot analysis
confirmed complete loss of FHbp expression in L915431fHbp
(Supplementary Figure S1). L915431fHbp + LfHbpSNP1
and L915431fHbp + LfHbpSNP2 showed moderate levels
of surface expression and L915431fHbp + LfHbpSNP1 + 2
showed a level of surface display comparable to MC58
(Figure 3). Interestingly Western immunoblot analysis
showed faster mobility, indicative of SP cleavage, for only
strain L915431fHbp + LfHbpSNP1 + 2, which had both
SNPs corrected but not for either recombinant strain with
individual SNPs corrected (Figure 3). Our results suggest that
both AA substitutions impact on the FHbp translocation-
processing pathway at some point up to, or at, the SP
cleavage step and surprisingly that repair of either SNP
individually can permit partial localization of FHbp to the
cell surface without the need for prior SP cleavage. This
was not expected for this sequential canonical lipoprotein
processing pathway.
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FHbp With SP SNPs Shows Reduced
Binding to SecA
Most proteins destined for the OM are first targeted to the
IM translocase, Sec-YEG, by the chaperone ATPase motor,
SecA. SecA recognizes SPs by having a high affinity for their
hydrophobic binding grooves and by electrostatically trapping
their positively charged n-region through acidic residues (Gelis
et al., 2007; Gouridis et al., 2009). We investigated the binding
of L91543 FHbp (carrying SNP1 and SNP2) to meningococcal
SecA and compared this to MC58 FHbp, which is known to
undergo cleavage and processing (Masignani et al., 2003; da Silva
et al., 2017). The bacterial two-hybrid approach was taken which
relies on induced expression of the two heterologous proteins
using E. coli as the host organism. The cytoplasmic readout
for binding affinity in this heterologous expression system is
expected to be similar to that in the meningococcus, prior to
translocation to the IM. Our results showed a significant 1.9-fold
lower binding of SecA to L91543 FHbp as compared to MC58
FHbp (Figure 4).
Clinical Isolates With FHbp SP SNPs
Show SP Retention Yet Surface
Localization
We next investigated the prevalence of FHbp containing SP
SNPs (that differ from the MC58 sequence) in the genome
sequences of all 1,895 invasive group B United Kingdom isolates
in the Meningitis Research Foundation (MRF) Meningococcus
Genome Library database collected between 2009 and 2017.
Unexpectedly we found that only 9% of isolates have a SP
identical to that of MC58 (referred to as class 1) with the
remaining isolates carrying either (i) both SNP1 and SNP2, like
L91543 (class 2, 23%); (ii) SNP2 alone (class 3, 48%); (iii) SNP2
and a third SNP (SNP3) (class 4, 17%), or (iv) other SNPs (3%)
(Table 1). All SNPs are located exclusively in the h-region 13
AA in length, and common to classes 2, 3, and 4 is SNP2 (i.e.,
T substituted by A at position 19).
To test if our findings for recombinant strains of L91543 apply
to these MRF isolates with non-class 1 FHbp, a selection of
isolates from each class were randomly selected (Table 2). Strain
H44/76 was chosen as an additional positive control strain since
its FHbp including SP is identical to that of MC58. FHbps of all
20 isolates belong to subfamily B/variant 1 (the most prevalent
group) and possess the JAR4 epitope (Beernink and Granoff,
2009) (Table 2 and Supplementary Table S1).
FHbp from all isolates with class 1 SP demonstrated a
similar size by SDS-PAGE to that of MC58 whilst all non-
class 1 FHbp proteins had the slower mobility observed for
L91543 (Figure 5A). To investigate the correlation between
electrophoretic mobility and surface localization, whole cell
immuno-dot blots were performed with JAR4 except for isolate
4 which JAR4 failed to recognize. For this isolate, polyclonal
anti-FHbp sera was used. The median level of surface expression
was highest for class 1 isolates and decreased progressively from
class 3 isolates (SNP2 only), to class 4 isolates (SNP2 and SNP3)
to class 2 isolates (SNP1 and SNP2) (Figure 5B). Overall, non-
class 1 isolates demonstrated a significant 2.2-fold lower surface
expression of FHbp than class 1 isolates (excluding isolate 4)
(Figure 5B). These results indicate a failure to cleave the SP
decreases the efficiency, but does not abrogate, localization
of FHbp to the surface. This data support our findings for
recombinant strains of L91543 (Figure 3). In contrast to the
general pattern, three isolates (L91543, 12 and 13) demonstrated
the presence of FHbp by Western immunoblot but no localization
to the cell surface by immuno-dot blot (Figure 5B). The cause of
this is explored later in this manuscript.
Interestingly all strains shown to express uncleaved FHbp in
this study carry SNP2: substitution of the polar T residue with a
hydrophobic A residue at position 19. The importance of polar
residues in the h-region of the SP of bacterial lipoproteins first
came to light in the late 1970s. In all but one of the 26 bacterial
SPs known at that time, polar residues; serine (S) and/or T were
found in the h-region and within close proximity to the signal
peptidase cleavage site (Vlasuk et al., 1984). A T16A mutant
within the SP of E. coli Lpp lipoprotein affected the rate of
processing with accumulation of unmodified precursor in the
membrane fraction (Vlasuk et al., 1984). It was postulated that
this T residue either directly affected recognition by Lgt or LspA
or affected IM translocation hindering accessibility of the SP by
these enzymes. We questioned whether the meningococcal Lgt
and LspA enzymes fail to recognize FHbp with class 2 (SNP1 and
SNP2), class 3 (SNP2), and class 4 (SNP2 and SNP3) SPs (Table 1)
and how these preprolipoproteins localize to the surface.
FHbp With SP SNPs Localize to the
Surface via Lnt and Slam With Escape
From Processing by Lgt and LspA
To test if strains with SP SNPs in FHbp are affected in lipid
modification, one isolate representative of each SP class was
tested for the presence of the lipid moiety. These included
MC58 (class 1), L91543 (class 2), isolate 6 (class 3) and isolate
18 (class 4) (Tables 1, 2). The strains were grown in medium
containing palmitic acid alkyne, FHbp was immuno-precipitated
then conjugated (clicked) with biotin azide, which attaches
exclusively to proteins carrying this alkyne. Western immunoblot
analyses were performed separately with streptavidin and with
JAR4. A band of the expected mobility for cleaved FHbp was
detected by streptavidin for MC58 clicked with biotin azide
and not for the corresponding non-clicked control as expected
(Figure 6A). However, no bands were detected for L91543, isolate
6 or 18 whether clicked or non-clicked, suggesting that the
FHbp molecules of these three isolates are not lipidated. The
absence of lipid by Lgt activity would explain the subsequent
failure of LspA to cleave the SP of these isolates (Figure 5A).
A recent study in E. coli showed that prevention of diacylglyceryl
modification at the conserved cysteine residue of Lpp, by Lgt
depletion, prevented Lsp from processing the SP as inferred
from its electrophoretic mobility (May et al., 2019). This
supports earlier studies that demonstrated that substitution of
the Cys residue of Lpp prevented diacylglyceryl modification
with accumulation of Lpp exclusively of slower mobility and
of the size expected for the unprocessed preprolipoprotein
(Inouye et al., 1983).
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FIGURE 3 | SP SNPs in FHbp prevent cleavage but not surface localization. Whole cell suspensions and WCL from fresh plate cultures analyzed by immuno-dot blot
(upper panel) and Western immunoblot (lower panel) respectively with JAR4. Lanes; 1, L915431fHbp + LfHbp; 2, L915431fHbp + LfHbpSNP1; 3,
L915431fHbp + LfHbpSNP2; 4, L915431fHbp + LfHbpSNP1 + 2, representative of three independent experiments. The density of spots was measured by ImageJ
and the one way ANOVA followed by Dunnett’s test was employed for statistical analysis in GraphPad (V. 6). All columns represent mean ± SEM, ∗p < 0.05 vs.
strain MC58.
Following failure of Lgt and LspA to lipidate and process
FHbp in these non-class 1 strains, we expected the remaining
canonical pathway not to be further employed and for the
preprolipoprotein to be translocated to the OM and surface
exposed by other mechanisms. To verify discontinuation of the
canonical pathway, the lnt gene of the four strains was disrupted.
Other than for the L91543 isogenic strains which both showed
the expected low level of FHbp, the Lnt mutant version of the
other three strains showed a significant reduction in surface
localization as well as diminished total FHbp (Figure 6B). This
supports our previous study where we showed that MC58Lnt
employs mechanisms to reduce FHbp levels thereby preventing
the toxic accumulation of the diacylated lipoprotein in the
periplasm (da Silva et al., 2017). Our data thus suggests that
in addition to the established role of Lnt in triacylating the
N-terminal Cys residue in class 1 strains with intact SP (as shown
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FIGURE 4 | FHbp with SP SNPs shows reduced binding to SecA. Bacterial two hybrid experiments to compare FHbp binding to SecA in MC58 and L91543. The
fHbp gene of strains MC58 and L91543 and secA gene of MC58 were cloned into the two-hybrid pUT18 (T18-prey) and pKT25 (T25-bait) vectors respectively and
the appropriate prey and bait pair of vectors co-transformed in BTH101. In parallel, zip prey and zip bait vectors were co-transformed in BTH101 as a positive
control for protein–protein interaction. Likewise, different prey-bait combinations but with one vector or both vectors empty were used as negative controls. The
interactions were quantified by measuring the β-galactosidase level expressed in Miller units (values taken from four independent clones). Unpaired t-tests with
Welsch’s correction were conducted to compare the interactions. All columns represent mean ± SEM, ∗p < 0.05 vs. MC58 FHbp.
for MC58) (da Silva et al., 2017), Lnt plays a role in delivering
FHbp to the OM without the requirement for prior processing
by LspA and Lgt.
Given that the canonical pathway appears to resume by
Lnt, we questioned whether Lol was employed to translocate
FHbp of these strains to the OM however it was not
possible to mutate any of the Lol-encoding genes. We next
investigated if Slam plays a role in the surface localization of
FHbp in these strains. Again with the exception of the poor
FHbp expressor, L91543, the disruption of Slam resulted in
significantly reduced surface localization of FHbp as well as
some reduction in total FHbp (Figure 6C). This suggests that
Slam plays a role in surface localization of FHbp regardless of
whether FHbp is processed or not. This contradicts what was
proposed by Hooda et al. (2016) that Slams are responsible
for transport of surface lipoproteins that possess a lipid anchor
that needs to be flipped from the inner leaflet to the outer
leaflet of the OM (Hooda et al., 2016). Rather, in this study
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FIGURE 5 | Comparison of FHbp size and surface localization in clinical isolates. For all non-class 1 isolates, the SP is uncleaved yet for most of these isolates,
FHbp is surface localized. WCL or whole cell suspensions were prepared from fresh plate cultures and JAR4 used except where indicated. (A) Western immunoblot.
For isolate 4, polyclonal anti-FHbp antibody was also used. Arrows indicate faster mobility FHbp. (B) Whole cell immuno-dot blot. The density of spots was
measured by ImageJ and the one way ANOVA followed by Dunnett’s test employed for statistical analysis in GraphPad (V. 6). All columns represent mean ± SEM,
∗p < 0.05 vs. class 1. Pooled data of class 1 and non-class 1 were analyzed using un-paired t-tests with Welsch’s correction. Both columns represent
mean ± SEM, ∗p < 0.05 vs. class 1.
we show that surface localization by Slam is not restricted
to lipoproteins.
Given our finding that FHbp with SP SNPs binds less well to
SecA, affecting its translocation efficiency to the IM, yet can be
translocated to the OM and subsequently surface localized by
Slam, we would expect this to be reflected in the sub-cellular
distribution of FHbp. In MC58 a processed FHbp protein of
27 kDa was found in the IM, periplasm and OM but was
barely detectable in the cytoplasm, providing strong evidence
of highly efficient translocation from cytoplasm to the IM but
less efficient translocation to the OM (Figure 6D). In contrast,
for isolates 6 and 18, unprocessed precursor was detected in all
four cellular compartments; cytoplasm, IM, periplasm and OM,
and at high levels in all (Figure 6D). These findings demonstrate
that the efficiency of translocation from cytoplasm to IM is
reduced in these isolates supporting our BACTH data (Figure 4)
but their OM translocation efficiency is comparable with that
of MC58. For strain L91543, the total, unprocessed precursor
FHbp was noticeably less abundant and all of this localized to
the IM and periplasm suggesting complete translocation across
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FIGURE 6 | FHbp with SP SNPs localize to the surface via Lnt and Slam with escape from processing by Lgt and LspA. (A) Western immunoblot after growing
strains in palmitic acid alkyne and clicking immuno-precipitated FHbp with biotin-azide; Streptavidin-HRP (upper panel) and JAR4 (lower panel). (B,C) Immuno-dot
blot of broth cultures (A600 0.5) and Western immunoblot of WCL with JAR4. For immuno-dot blot densitometer values, unpaired t-tests with Welsch’s correction
were conducted to compare the isogenic strains. All columns represent mean ± SEM, ∗p < 0.05 vs. wild type isogenic strain. (D) Western immunoblot of different
cellular fractions with JAR4. (Lane 1, MC58; 2, L91543; 3, isolate 6; 4, isolate 18.) (B–D) Equal protein loading was confirmed by the determination of RecA protein
in each sample.
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the IM (Figure 6D). Conversely, for isolates 6 and 18, the
greater overall abundance of the unprocessed precursor appears
to have exceeded the capacity of SecA to fully translocate it.
From this, we hypothesize that when the unprocessed precursor
is abundant, SecA which is already hampered in its binding
affinity for non-class 1 FHbp, translocates only a portion of this
preprolipoprotein to the IM.
Transcript Level of fHbp Influences
Sub-Cellular Distribution and Surface
Localization of FHbp
We speculated that the poor expression of the FHbp
preprolipoprotein in L91543 was due to weak transcription of
fHbp, given that strains are known to vary in their transcription
efficiency for fHbp (Oriente et al., 2010; Sanders et al., 2012;
Cayrou et al., 2018). To test this, RNA was prepared from A600
1.0 broth cultures of all 20 strains and RT-PCR performed
with invariant fHbp-specific primers. L91543 exhibited 5.8-fold
reduction in fHbp transcript level, and a reduction of 4.6-fold was
observed for isolates 12 and 13, compared to MC58 (Figure 7).
These three isolates were the same isolates previously found
to display FHbp poorly at the cell surface (Figure 5B) hence
transcription efficiency influences surface abundance as expected.
To test our hypothesis that an abundance of non-class 1
FHbp exceeds the capacity for complete translocation across
the IM, strong expression of fHbp was induced in L91543
and changes in the subcellular distribution of FHbp were
investigated. This was made possible by exploiting strain
L915431fHbp + LfHbp wherein this class 2 fHbp is under the
control of the inducible lacZ promoter. First, the amount of
surface FHbp preprolipoprotein was compared by immuno-
dot blot between isopropyl-β-D-thiogalactopyranoside (IPTG)-
induced and non-induced L915431fHbp+ LfHbp, relative to the
L91543 parent strain and to MC58. The induced recombinant
strain localized unprocessed FHbp to the surface with a similar
level to that of MC58 (Figure 8A). In the absence of induction,
the preprolipoprotein localized to the periplasm and IM but very
poorly to the OM (Figure 8B) similar to that observed for the
L91543 parent strain (Figure 8B). Upon induction, not only
did the quantity of preprolipoprotein dramatically increase, as
expected, but as with isolates 6 and 18, some was retained in the
cytoplasm while the remainder localized to the IM, periplasm
and OM (Figure 8B). Together the data suggest that a certain
threshold level of FHbp in the periplasm is tolerated, as shown
for strain L91543 (Figure 6D) and non-induced recombinant
strain, L915431fHbp + LfHbp (Figure 8B). However, over-
accumulation in the periplasm appears to force translocation to
the OM as observed for induced L915431fHbp + LfHbp and for
isolates 6 and 18 (Figures 6D, 8B).
Comparison of Biological Activities of
Unprocessed and Processed Surface
FHbp
The binding of FHbp to fH is vital for the meningococcus
to inhibit bacteriolysis by the alternative pathway (Schneider
et al., 2006). Crystal structure studies reveal that FHbp folds
to form an N-terminal β barrel and a C-terminal β barrel
and that the FHbp-fH complex is held together by extensive
interactions between both β-barrels and domains 6 and 7 of fH
(Schneider et al., 2009). We questioned whether the inclusion of
the 26 AA SP at the N terminus of FHbp affects the binding of
FHbp to fH. Equivalent cell numbers of each of the 20 isolates
were incubated with fH. Anti-fH antibody binding was then
measured by Fluorescence-Activated Cell Sorting (FACS). No
significant difference in binding of class 1 versus non-class 1
isolates was found.
Since a certain threshold level of FHbp on the surface
of cells is required for successful killing by vaccine-induced
antibodies (Jiang et al., 2010; McNeil et al., 2018) we questioned
whether isolates with non-class 1 FHbp SP that typically display
less unprocessed FHbp at the surface may be more resistant
to killing by antibodies. First FHbp surface expression was
rigorously quantified by FACS analysis with JAR4. Since JAR4 is
a monoclonal antibody binding a single epitope (Supplementary
Table S1), saturation of meningococcal cells with this antibody
should result in the maximal binding of one antibody per FHbp
molecule. Commercially available microspheres were used to
quantify the number of antibodies bound per cell (ABC) and
enable us to infer from this the number of FHbp molecules
displayed per cell. The SBA assay was performed using the
FHbp-specific monoclonal antibody JAR5 along with JAR4.
Cooperativity between these two antibodies is necessary to elicit
bactericidal activity in the presence of human complement
(Beernink et al., 2008; Welsch et al., 2008; Malito et al., 2016).
JAR5 is known to bind the FHbp epitope comprising AA residues
84–91 and 115–123 (Malito et al., 2016) (Supplementary Table
S1). Since MC58 and L91543 were previously shown to contrast
starkly in their FHbp exposure and susceptibility to killing
by FHbp-immunized sera in SBA assays (Newcombe et al.,
2014) these strains were used as positive and negative controls
respectively to benchmark all other isolates.
We first noted that isolates 4, 12, and 13 displayed very
poor surface FHbp at a level comparable with that of L91543
(Figure 9A) supporting our previous immuno-dot blot data for
these isolates (Figure 5B). These levels were well below 757
molecules per cell, the threshold level for killing by anti-FHbp
antibodies (Biagini et al., 2016). Unsurprisingly, extremely weak
bactericidal activity was detected for these isolates in SBA assays
with up to 11% killing demonstrated (Figure 9B). Our findings
are explained by the poor transcript levels observed for isolates
L91543, 12, and 13 (Figure 7) and by failure of JAR4 to bind
isolate 4 (Figure 5B). Pooled class 1 isolates were compared with
pooled non-class 1 isolates after discounting the four outliers. For
ABC, the average was 7869 vs. 4547 molecules (p = 0.0038) and
for SBA the average was 73.7 vs. 53.4% (p = 0.0009) (Figure 9C).
DISCUSSION
Since the discovery of FHbp as a lipoprotein (Fletcher et al.,
2004) it has been assumed that all meningococci that express
FHbp synthesize the mature lipoprotein. The failure to process
FHbp including lipidation and SP cleavage, in strain L91543 was
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FIGURE 7 | Comparison of fHbp transcript level between strains. RT-PCR of fHbp and recA. One representative experiment of 3 is shown. Band intensity was
measured using Image lab v4.0.1 and the data acquired using Linear non-threshold model (lnt). The one-way ANOVA followed by Dunnett’s test was employed for
statistical analysis in GraphPad (V. 6). All columns represent mean ± SEM, ∗p < 0.05 vs. strain MC58.
FIGURE 8 | The affect of increasing transcription of fHbp on FHbp subcellular localization and surface localization in L91543. (A) Immuno-dot blot of whole cells with
JAR4. Lanes; 1, MC58, 2, L91543, 3, L915431fHbp + LfHbp induced with IPTG, 4, L915431fHbp + LfHbp non-induced. One representative experiment of 5 is
shown. The optical density was measured by ImageJ. The ANOVA followed by Dunnett’s test was employed for statistical analysis in GraphPad (V. 6). All columns
represent mean ± SEM, ∗p < 0.05 vs. strain L91543. (B) Western immunoblot with JAR4 of different subcellular compartments of strain L915431fHbp + LfHbp
non-induced versus induced. Equal protein loading was confirmed by the determination of RecA protein.
directly linked to mutations in the SP (L15F) and (T19A) that
interrupt Sec-mediated translocation. The correlation between
SP mutations and failure to process FHbp was further confirmed
in a panel of invasive group B isolates. Remarkably the
preprolipoprotein of isolates possessing variant SPs localized to
the cell surface but with twofold lower abundance and in the
subset of isolates tested, this was attributed to its partial retention
in the cytoplasm. For L91543 with poor transcription of fHbp,
the less abundant preprolipoprotein was all translocated across
the IM but none was translocated to the OM for subsequent
surface display. This could however be overcome by increasing
the transcription strength of fHbp.
It is known that Sec-dependent proteins are exported in
unfolded states to the Sec-YEG channel (Figure 1) as this channel
is only large enough to accommodate unfolded proteins (Li
et al., 2016). SecA acts promptly to bind nascent polypeptides
as they emerge from the ribosome during translation and
maintains the polypeptide in an unfolded state (Huber et al.,
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FIGURE 9 | Comparison of biological activities of unprocessed and processed surface-localized FHbp. (A) FACS analysis with Mab JAR4. A representative flow
cytometry plot for each isolate is shown. The read-outs from negative control samples, cells incubated with secondary antibody only (left peak) were gated (as
shown by the arrows). The read-outs from samples incubated with both primary and secondary antibody were overlaid. (B) The number of JAR4 antibody molecules
bound per cell (ABC) and corresponding prediction for successful killing in SBA assays is denoted by +. The actual percentage killing for each isolate with Mabs
JAR4, JAR5 and human complement is shown. The mean ABC for each isolate was derived from three independent FACS experiments and the mean percentage
killing derived from four independent SBA experiments, each with two technical replicates. The binding of fH to cells. Values show the Relative Mean of Fluorescence
Intensity (rMFI) for total fluorescing cells after incubation with fH and anti-fH PE-conjugated antibody. The values were normalized against the negative control of cells
alone incubated with antibody. (C) Pooled data for class 1 and non-class 1 isolates, excluding the outliers. Values were analyzed by unpaired t-tests with Welsch’s
correction. Columns represent mean ± SEM, ∗p < 0.05 vs. class 1.
2017). Disrupting this interaction causes a partial defect in
SecA-mediated translocation (Huber et al., 2017) and reduced
efficiency of transport to the IM due to the propensity for
the preprolipoprotein to fold and become incompetent for
translocation (Steiner et al., 2006). Based on new insights in
SecA-mediated translocation (Mao et al., 2016), it is possible
that the preprolipoprotein that is translocated is not orientated
correctly in the IM such that Lgt fails to recognize this FHbp
precursor as substrate.
Our findings suggest that the polar AA, threonine (T), four
AAs away from the lipobox of FHbp, is the most critical for
correct translocation by SecA in MC58 as the T19A mutation is
carried by all non-class 1 isolates (at least 88% of MRF isolates)
and is the sole mutation in class 3 isolates (48% of MRF isolates)
(Table 1). This supports the work of Vlasuk and co-workers who
in the early 80s demonstrated the importance of polar residues
close to the lipobox of E. coli Lpp, for translocation (Vlasuk
et al., 1984). We postulate that in T19A FHbp variants, the
reduced efficiency of binding to the SP by SecA results in the
propensity for folding with consequent retention of some of this
translocation-incompetent preprolipoprotein in the cytoplasm.
This retention was evident for both isolates 6 and 18 tested that
express an abundance of the preprolipoprotein and for L91543
after induction of strong expression of FHbp (Figures 6D, 8B).
The remaining preprolipoprotein was translocated across the
IM and some of this was translocated to the OM and further
surface-displayed. It is plausible that the SP anchors FHbp to the
OM facilitated by its hydrophobic region. Upon accumulation of
the unprocessed precursor FHbp in the IM beyond a threshold
level, translocation to the OM is forced, probably to prevent
clogging which would prohibit the translocation of other OM-
destined proteins and be potentially fatal for the cell. We provide
data suggesting this translocation is partly mediated by Lnt
highlighting a secondary role for Lnt as a chaperone facilitating
delivery to Lol. We further show that localization to the surface
involves Slam revealing that Slam is not lipoprotein-specific. The
broader specificity of Slam, than originally thought, for OM
protein localization is plausible given Slam recognizes the C
terminal structure of its substrates (Hooda et al., 2016) which may
be shared between lipoproteins and OM proteins.
From analysis of the SP sequence of 1895 invasive group B
isolates from the United Kingdom MRF collection, as few as 9%
are predicted to express FHbp as a lipoprotein. Conversely, at
least 88% are predicted to display the unprocessed, precursor at
the surface, provided sufficient transcription strength of fHbp.
A similar prevalence is expected for other isolates circulating
around the globe. Given that isolates displaying non-class 1
FHbp SP are far more prevalent than class 1 isolates, there
must be a fitness benefit for the former. One explanation for
evolutionary selection for the former could be that exportation
of unprocessed FHbp is less metabolically costly than employing
processing enzymes to modify FHbp prior to localization of the
mature lipoprotein to the surface. Alternatively the significantly
reduced surface exposure of the preprolipoprotein, shown in
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this study, may be selected for to reduce anti-FHbp antibody-
mediated killing whilst retaining sufficient fH binding. It is
worth noting here that we would anticipate seeing even greater
differences in SBA responses between Class 1 and non-Class 1
isolates using sera from Trumenba-vaccinated individuals (as
opposed to the two Mabs used in this study) since this vaccine
specifically targets SP-cleaved, lipidated FHbp (Class 1 FHbp)
with polyclonal antibodies generated to multiple epitopes.
To summarize, our results reveal that the AA sequence
requirement for lipoprotein SPs to direct translocation to the
IM completely and correctly for processing to follow, are
more constrained than previously thought. In the DOLOP
database of predicted bacterial lipoproteins https://www.mrc-
lmb.cam.ac.uk/genomes/dolop/predicted/ab.shtml (Babu et al.,
2006) the algorithm does not include the requirement for the
polar residue and for many of the proteins in this database,
this residue is absent. These proteins are unlikely to undergo
maturation to become lipoproteins and thus the size of bacterial
lipoproteomes could be over-estimated. More experimental work
is required for other bacterial lipoproteins to fully determine the
structural features, in particular, critical AAs, that are required
for lipoprotein maturation and localization. From this, new
programs with greater prediction power can be deployed which
would be of importance to scientists developing vaccines based
on bacterial lipoproteins, a growing area of research.
Finally, our finding that the FHbp vaccine target is
predominantly unprocessed FHbp as opposed to cleaved,
lipidated FHbp, is particularly important for Trumenba which is
composed exclusively of 2 lipidated variants of FHbp. Altering
the vaccine to contain uncleaved, non-lipidated FHbp should
improve its target specificity. It is unknown to the public
which reference strains are used in Pfizer’s MEASURE assay
(Meningococcal Antigen Surface Expression) (Donald et al.,
2017) as standards for quantifying FHbp surface abundance on
test isolates in order to predict vaccine coverage. With knowledge
of the prevalence of 4 SP classes for FHbp – the majority of
isolates expressing non-class 1, the choice of reference strains
should be re-considered to ensure sufficient representation across
these classes. In predicting coverage by Trumenba, knowledge
on the nucleotide level of promoter and upstream regulatory
sequences (Cayrou et al., 2018) and on the AA level of the SP
sequence are both key as the former dictates FHbp expression
level and the latter its sub-cellular distribution and importantly
surface localization. This sequence information will enable an
improved understanding of Trumenba vaccine escape strains and
this knowledge can feed into developing improved formulations.
Our findings also bear relevance for Bexsero although this vaccine
is multivalent and thus less heavily reliant on the successful
targeting of FHbp. Our study highlights the importance of
multivalent vaccine approaches.
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FIGURE S1 | Western immunoblotting of WCL of L91543 and L915431fHbp with
JAR4.
TABLE S1 | Multiple alignment of FHbp of isolates used in this study and AA
identities across the whole protein relative to MC58. Framed in red and gray boxes
are AA residues in the epitopes recognized by JAR4 and JAR5 respectively.
TABLE S2 | AA identity of proteins involved in translocation, processing and
surface localization of FHbp in L91543 compared to MC58.
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